Guska

Guska develops solutions based on synthetic RNA oncolytic virus therapy that have potent and safe immunostimulatory effects to address the pain point of cancer treatment by providing a targeted and less harmful alternative to traditional therapies. Our technology uses synthetic RNA viruses designed... Read more